Crossmark

A Community-based Assessment of Skin Care, Allergies, and Eczema (CASCADE): an atopic dermatitis primary prevention study using emollients—protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-020-4150-5

Published Online: 2020-03-04

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Eichner, Brian

Michaels, Le Ann C.

Branca, Kelsey

Ramsey, Katrina

Mitchell, Julie

Morris, Cynthia D.

Fagnan, Lyle J.

Dolor, Rowena J.

Elder, Nancy

Hahn, David L.

Nease, Donald E.

Lapidus, Jodi

Cibotti, Ricardo

Block, Julie

Simpson, Eric L.
Funding

Funding for this research was provided by:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR107517)

Oregon Clinical and Translational Research Institute (UL1TR002369)
License Information

Text and Data Mining valid from 2020-03-04

Version of Record valid from 2020-03-04
More Information

Article History

Received: 25 November 2019

Accepted: 6 February 2020

First Online: 4 March 2020

Ethics approval and consent to participate

: The study has been reviewed and approved by the Trial Innovation Network Single IRB at the University of Utah (IRB_00106351, initial approval February 7, 2018) for all participating sites with reliance from each regional IRB. The trial is registered at(ID: NCT03409367). Informed consent will be obtained from all study participants enrolled into the trial. Protocol amendments will be approved by the University of Utah and local IRBs, and shared with the Data and Safety Monitoring Board.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below